hieunguyen1053 commited on
Commit
b7ce4cd
1 Parent(s): f632b52

Update README.md

Browse files
Files changed (1) hide show
  1. README.md +27 -1
README.md CHANGED
@@ -68,7 +68,7 @@ def preprocess(sample):
68
  - Format for Rationale task
69
 
70
  ```python
71
- def preprocess(sample):
72
  premise = sample['premise']
73
  hypothesis = sample['hypothesis']
74
  rationale = sample['reason']
@@ -78,4 +78,30 @@ def preprocess(sample):
78
  """
79
  <|startoftext|><|premise|> TOKYO, Dec 18 (Reuters) - Japan’s Shionogi & Co said on Tuesday that it has applied to health regulators in the United States, Canada and Europe for approval of its HIV drug Dolutegravir. Shionogi developed Dolutegravir with a Viiv Healthcare, an AIDS drug joint venture between GlaxoSmithKline and Pfizer, in exchange for its rights to the drug. <|hypothesis|> The article was written on December 18th. <|rationale|> TOKYO, Dec 18 (Reuters) is when the article was written as it states in the first words of the sentence <|endoftext|>
80
  """
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
81
  ```
 
68
  - Format for Rationale task
69
 
70
  ```python
71
+ def preprocess_rationale(sample):
72
  premise = sample['premise']
73
  hypothesis = sample['hypothesis']
74
  rationale = sample['reason']
 
78
  """
79
  <|startoftext|><|premise|> TOKYO, Dec 18 (Reuters) - Japan’s Shionogi & Co said on Tuesday that it has applied to health regulators in the United States, Canada and Europe for approval of its HIV drug Dolutegravir. Shionogi developed Dolutegravir with a Viiv Healthcare, an AIDS drug joint venture between GlaxoSmithKline and Pfizer, in exchange for its rights to the drug. <|hypothesis|> The article was written on December 18th. <|rationale|> TOKYO, Dec 18 (Reuters) is when the article was written as it states in the first words of the sentence <|endoftext|>
80
  """
81
+ ```
82
+
83
+ - Format for GPT-3
84
+
85
+ ```python
86
+ def preprocess_gpt3(sample):
87
+ premise = sample['premise']
88
+ hypothesis = sample['hypothesis']
89
+ label = sample['label']
90
+
91
+ if label == 0:
92
+ output = f'\n<|correct|> True\n<|incorrect|> False\n<|incorrect|> Neither'
93
+ elif label == 1:
94
+ output = f'\n<|correct|> Neither\n<|incorrect|> True\n<|incorrect|> False'
95
+ else:
96
+ output = f'\n<|correct|> False\n<|incorrect|> True\n<|incorrect|> Neither'
97
+
98
+ return {'text': f'<|startoftext|> anli 2: {premise} <|question|> {hypothesis}\nTrue, False, or Neither? <|answer|> {output} <|endoftext|>'}
99
+
100
+ """
101
+ <|startoftext|> anli 2: TOKYO, Dec 18 (Reuters) - Japan’s Shionogi & Co said on Tuesday that it has applied to health regulators in the United States, Canada and Europe for approval of its HIV drug Dolutegravir. Shionogi developed Dolutegravir with a Viiv Healthcare, an AIDS drug joint venture between GlaxoSmithKline and Pfizer, in exchange for its rights to the drug. <|question|> The article was written on December 18th.
102
+ True, False, or Neither? <|answer|>
103
+ <|correct|> True
104
+ <|incorrect|> False
105
+ <|incorrect|> Neither <|endoftext|>
106
+ """
107
  ```